MedTrace Logo

Web-Based Follow-Up Using Cellular Phone in Type 1 Diabetic Patients Under Insulin Pump Therapy : The PumpNet Study

NCT00324584 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2006-07-07

No results posted yet for this study

Summary

The purpose of this study is to determine if telecare using modern telecommunication devices can improve the metabolic control and the quality of life of type 1 diabetic patients.

Conditions

  • Type 1 Diabetes Mellitus

Interventions

DEVICE

Telemonitoring of glucose values using GlucoNet device

Sponsors & Collaborators

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Pierre Y Benhamou, MD, PhD · Universty Hospital, Grenoble, France

  • Helene Hanaire, MD, PhD · University Hospital, Toulouse, France

  • Serge Halimi, MD · University Hospital, Grenoble, France

  • Jean L Bosson, MD, PhD · CIC-INSERM

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-04-30
Completion
2004-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00324584 on ClinicalTrials.gov